Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Dopa decarboxylase genotypes may influence age at onset of schizophrenia

Abstract

Several lines of evidence implicate dopa decarboxylase (DDC) with schizophrenia. By analysis of two putative functional DDC variants in 173 schizophrenic patients and 204 controls we tested the hypotheses that DDC is involved in: (1)?predisposition to schizophrenia; and (2)?modulation of age at disease onset. No association was observed with schizophrenia as a whole, whereas an association between DDC genotypes and age at disease onset was suggested in males (P?=?0.03). This association was most pronounced in relation to genotypes of haplotypes comprising both variants, suggesting an additive model where one variant mediates early and the other late onset. Accordingly, the haplotype-based genotypes could be assigned into three groups by their possible relative effect on age at onset: an ‘early’, ‘neutral’ and ‘late’ group. Dividing the male schizophrenics into four groups with increasing age at onset, the ‘early’ genotypes were seen to decrease in frequency from 51.5% to 16.7% while the ‘late’ genotypes increased from 12.1% to 33.3% (P?=?0.02). The difference in mean age at onset between male patients with ‘early’ genotypes vs patients with ‘late’ genotypes was close to 5 years (95% CI: 0.7–8.8). Thus, DDC may possibly act as a modulator of age at onset in male schizophrenics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Davis KL, Kahn RS, Ko G, Davidson M . Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 1991 148: 1474–1486

    Article  CAS  Google Scholar 

  2. Waddington JL . Schizophrenia: developmental neuroscience and pathobiology Lancet 1993 341: 531–536

    Article  CAS  Google Scholar 

  3. Weinberger DR . Neurodevelopmental perspectives on schizophrenia. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995 1171–1183

    Google Scholar 

  4. Christenson JG, Dairman W, Udenfriend S . On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine) Proc Natl Acad Sci USA 1972 69: 343–347

    Article  CAS  Google Scholar 

  5. Davis BA, Shrikhande S, Paralikar VP, Hirsch SR, Durden DA, Boulton AA . Phenylacetic acid in CSF and serum in Indian schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 1991 15: 41–47

    Article  CAS  Google Scholar 

  6. O'Reilly R, Davis BA, Durden DA, Thorpe L, Machnee H, Boulton AA . Plasma phenylethylamine in schizophrenic patients Biol Psychiatry 1991 30: 145–150

    Article  CAS  Google Scholar 

  7. Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis Proc Natl Acad Sci USA 1994 91: 11651–11654

    Article  CAS  Google Scholar 

  8. Buckland PR, Marshall R, Watkins P, McGuffin P . Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels Brain Res Mol Brain Res 1997 49: 266–270

    Article  CAS  Google Scholar 

  9. Angermeyer MC, Kuhn L . Gender differences in age at onset of schizophrenia. An overview Eur Arch Psychiatry Neurol Sci 1988 237: 351–364

    Article  CAS  Google Scholar 

  10. Hafner H, Behrens S, De Vry J, Gattaz WF . An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia Psychiatry Res 1991 38: 125–134

    Article  CAS  Google Scholar 

  11. Børglum AD, Bruun TG, Kjeldsen TE, Ewald H, Mors O, Kirov G et al. Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder Mol Psychiatry 1999 4: 545–551

    Article  Google Scholar 

  12. Speight G, Turic D, Austin J, Hoogendoorn B, Cardno AG, Jones L et al. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder Mol Psychiatry 2000 5: 327–331

    Article  CAS  Google Scholar 

  13. Terwilliger JD, Ott J . Handbook of Human Genetic Linkage The Johns Hopkins University Press: Baltimore, London 1994

    Google Scholar 

  14. Meltzer HY, Maes M, Lee MA . The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine Psychopharmacology (Berl) 1993 112: S95–S104

    Article  CAS  Google Scholar 

  15. Kolakowska T, Williams AO, Ardern M, Reveley MA, Jambor K, Gelder MG et al. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction Br J Psychiatry 1985 146: 229–239

    Article  CAS  Google Scholar 

  16. Nimgaonkar VL, Wessely S, Tune LE, Murray RM . Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement Psychol Med 1988 18: 583–592

    Article  CAS  Google Scholar 

  17. Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P et al. Long-term course of hospitalization for schizophrenia: Part I. Risk for rehospitalization Schizophr Bull 1992 18: 217–228

    Article  CAS  Google Scholar 

  18. Meltzer HY, Rabinowitz J, Lee MA, Cola PA, Ranjan R, Findling RL, Thompson PA . Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance Am J Psychiatry 1997 154: 475–482

    Article  CAS  Google Scholar 

  19. Johnstone EC, Owens DG, Bydder GM, Colter N, Crow TJ, Frith CD . The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates Psychol Med 1989 19: 91–103

    Article  CAS  Google Scholar 

  20. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR . Duration of psychosis and outcome in first-episode schizophrenia Am J Psychiatry 1992 149: 1183–1188

    Article  CAS  Google Scholar 

  21. Häfner H, Riecher-Rossler A, Maurer K, Fatkenheuer B, Loffler W . First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences Eur Arch Psychiatry Clin Neurosci 1992 272: 109–118

    Article  Google Scholar 

  22. Bellodi L, Morabito A, Macciardi F, Gasperini M, Benvenuto MG, Grassi G et al. Analytic considerations about distribution of age of onset in schizophrenia Neuropsychobiology 1982 8: 93–101

    Article  CAS  Google Scholar 

  23. Rzewuska M, Angst J . Aspects of the course of bipolar manic-depressive, schizo-affective, and paranoid schizophrenic psychoses Arch Psychiatr Nervenkr 1982 231: 487–501

    Article  CAS  Google Scholar 

  24. Beratis S, Gabriel J, Hoidas S . Age at onset in subtypes of schizophrenic disorders Schizophr Bull 1994 20: 287–296

    Article  CAS  Google Scholar 

  25. Ellinwood EH, Jr, Sudilovsky A, Nelson LM . Evolving behavior in the clinical and experimental amphetamine (model) psychosis Am J Psychiatry 1973 130: 1088–1093

    Article  Google Scholar 

  26. Snyder SH . Amphetamine psychosis: a ‘model’ schizophrenia mediated by catecholamines Am J Psychiatry 1973 130: 61–67

    Article  CAS  Google Scholar 

  27. Buckland PR, Spurlock G, McGuffin P . Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels Brain Res Mol Brain Res 1996 35: 69–76

    Article  CAS  Google Scholar 

  28. Endicott J, Spitzer RL . A diagnostic interview: the schedule for affective disorders and schizophrenia Arch Gen Psychiatry 1978 35: 837–844

    Article  CAS  Google Scholar 

  29. Spitzer RL, Endicott J, Robins E . Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd edn New York State Psychiatric Institution: Biometrics Research Division 1978

    Google Scholar 

Download references

Acknowledgements

The study was supported by grants from the Danish Medical Research Council (9602007), the Scottish Medical Research Council (grant to Drs D Blackwood and W Muir), the European Union (BMH4-CT97-2466), the Psychiatric Research Foundation, the Eli and Egon Larsen Foundation, the Geert-Jørgensen Foundation, the Jacob Madsen Foundation, and the Axel Thomsen Foundation. Dr V Murray is supported by a Sim Fellowship from the Royal College of Physicians of Edinburgh. We are grateful for the help of the Regional Blood transfusion Service, Edinburgh. Anette B Kvistgaard and Peter Lodge are acknowledged for excellent laboratory work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A D Børglum.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Børglum, A., Hampson, M., Kjeldsen, T. et al. Dopa decarboxylase genotypes may influence age at onset of schizophrenia. Mol Psychiatry 6, 712–717 (2001). https://doi.org/10.1038/sj.mp.4000902

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000902

Keywords

This article is cited by

Search

Quick links